Influence of Serratia marcescens and Rhodococcus rhodnii on the Humoral Immunity of Rhodnius prolixus

Int J Mol Sci. 2021 Oct 9;22(20):10901. doi: 10.3390/ijms222010901.

Abstract

Chagas disease is a human infectious disease caused by Trypanosoma cruzi and can be transmitted by triatomine vectors, such as Rhodnius prolixus. One limiting factor for T. cruzi development is the composition of the bacterial gut microbiota in the triatomine. Herein, we analyzed the humoral immune responses of R. prolixus nymphs treated with antibiotics and subsequently recolonized with either Serratia marcescens or Rhodococcus rhodnii. The treatment with antibiotics reduced the bacterial load in the digestive tract, and the recolonization with each bacterium was successfully detected seven days after treatment. The antibiotic-treated insects, recolonized with S. marcescens, presented reduced antibacterial activity against Staphylococcus aureus and phenoloxidase activity in hemolymph, and lower nitric oxide synthase (NOS) and higher defensin C gene (DefC) gene expression in the fat body. These insects also presented a higher expression of DefC, lower prolixicin (Prol), and lower NOS levels in the anterior midgut. However, the antibiotic-treated insects recolonized with R. rhodnii had increased antibacterial activity against Escherichia coli and lower activity against S. aureus, higher phenoloxidase activity in hemolymph, and lower NOS expression in the fat body. In the anterior midgut, these insects presented higher NOS, defensin A (DefA) and DefC expression, and lower Prol expression. The R. prolixus immune modulation by these two bacteria was observed not only in the midgut, but also systemically in the fat body, and may be crucial for the development and transmission of the parasites Trypanosoma cruzi and Trypanosoma rangeli.

Keywords: antibiotic; aposimbiotic; bacteria; insect immunity; insect physiology; microbiota; triatomine.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Defensins / metabolism
  • Fat Body / metabolism
  • Gastrointestinal Microbiome / drug effects
  • Gene Expression Regulation / drug effects
  • Immunity, Humoral
  • Insect Proteins / metabolism
  • Monophenol Monooxygenase / metabolism
  • Nitric Oxide Synthase / metabolism
  • Rhodnius / drug effects
  • Rhodnius / immunology
  • Rhodnius / metabolism
  • Rhodnius / microbiology*
  • Rhodococcus / immunology*
  • Serratia marcescens / immunology*
  • Staphylococcus aureus / physiology

Substances

  • Anti-Bacterial Agents
  • Defensins
  • Insect Proteins
  • Nitric Oxide Synthase
  • Monophenol Monooxygenase

Supplementary concepts

  • Rhodococcus rhodnii